Indication

Portfolio expansion: RIDA®UNITY E. coli Stool Panel I and III working together Current situation: Differentiating pathogenic E. coli strains is becoming increasingly important in gastrointestinal [...]

Gastrointestinal infections pose a significant global health concern GI infections stand as the fourth leading cause of death worldwide among children under 5 years old. These infections, caused [...]

Please note: The proof of chlamydia trachomatis serotypes L1- L3 is to be reported since September 2022 We would like to draw your attention to the crucial importance of differentiating between [...]

Analysis of stool samples is a frequent task in clinical diagnostics. Heike Calado Duarte and Carlo Farah from our R&D team talk to us about the challenges involved and what you should pay [...]

Respiratory diseases often show similar symptoms, but are triggered by a variety of pathogens, such as viruses, bacteria and fungi. Rapid, comprehensive and reliable diagnostics as a basis for [...]

The bacteria Clostridium difficile colonizes every human intestine, although it may be harmful for those with compromised immune systems. It is becoming increasingly prevalent in hospitals. What [...]

Studies have shown that some patients do not respond or respond inadequately to therapies for chronic intestinal diseases like for example Inflammatory Bowel Disease. The biologic drug [...]

Therapeutic drug monitoring (TDM) for the biological Vedolizumab has not been in focus to date. Vedolizumab is a meant or the treatment for inflammatory bowel disease. On Wednesday, September 29, [...]

For World IBD Day we would like to draw your attention to the Inflammatory Bowel Disease (IBD). About ten million people worldwide (around three million in Europe) suffer from this chronic [...]

The COVID-19 infection figures continue to rise and with them the fear: How long can regular school operations be maintained? Experts warn of renewed school closings and recommend specific measures.